Thus, A2AR antagonists certainly act at neuronal targets but also restore the activated/amoeboid, neuroinflammatory microglia to its resting/surveying state in an MPTP (selective dopaminergic neurotoxin) model of PD [163]. Here, ADORA2A is linked to Parkinson disease.